Imagin Medical, Inc. engages in the research, development, and commercialization in the device and instrumentation medical technology industry. The company is headquartered in Vancouver, British Columbia. The firm is engaged in developing technologies to better visualize and treat urologic cancers through minimally invasive surgery, including bladder and prostate cancer. Its first product, enCAGE Coil, is designed to eliminate the limitations of other methods of prostate cancer treatment that can cause erectile dysfunction and urinary incontinence. The device is a disposable, focal therapy, precision ablation system that delivers bipolar, radio frequency energy through a distinctive coil electrode, or cage. The company enables the surgeon to preset margins for precise tissue targeting. Its second product, the i/Blue Imaging System, will bring several key technological advancements that improve the utility of blue light imaging for visualizing bladder cancer. The i/Blue System delivers blue light imaging technology in a more versatile, practical, and accessible format and is designed to work with existing fiberoptic endoscopes on the market.
Imagin Medical Inc.'in temel mali tabloları nelerdir?
Son mali tabloya (Form-10K) göre, Imagin Medical Inc.'in toplam varlıkları $1 olup, net 손실 $-2'dir.
IMEXF'ün temel finansal oranları nelerdir?
Imagin Medical Inc.'in cari oranı 0.07, net kâr marjı 0, hisse başına satış $0'dir.
Imagin Medical Inc.'in geliri segment veya coğrafya bazında nasıl dağılıyor?
Imagin Medical Inc. 주요 수익원은 Apparel, Accessories and Equipment이며, 최신 수익 발표에서 수익은 2,712,390,000입니다. 지역별로는 United States이 Imagin Medical Inc.의 주요 시장이며, 수익은 1,979,033,000입니다.
Imagin Medical Inc. kârlı mı?
no, son mali tablolara göre Imagin Medical Inc.'in net 손실 $-2'dir.
Imagin Medical Inc.'in herhangi bir yükümlülüğü var mı?
예, Imagin Medical Inc.'in yükümlülüğü 14'dir.
Imagin Medical Inc.'in tedavüldeki hisse sayısı kaçtır?
Imagin Medical Inc.'in toplam tedavüldeki hisse sayısı 10.83'dir.